Trial intelligence / Profile preview

Rukeshu Capsule Phase II Trial in Mammary Gland Hyperplasia

CTR20150141Phase 2Active

Sponsor
Xianyang Licai Pharmaceutical
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of xiaoru sanjie in breast hyperplasia, sponsored by Xianyang Licai Pharmaceutical. Started Mar 2015; status: active.

02

Drugs

xiaoru sanjie
03

Conditions

breast hyperplasia

Beyond the preview

Go deeper on CTR20150141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call